Article
An experimental evaluation of drug‐induced mutational meltdown as an antiviral treatment strategy
27 Aug 2016
Abstract excerpt
The rapid evolution of drug resistance remains a critical public health concern. The treatment of influenza A virus (IAV) has proven particularly challenging, due to the ability of the virus to develop resistance against current antivirals and vaccines. Here, we evaluate a novel antiviral drug therapy, favipiravir, for which the mechanism of action in IAV involves an interaction with the viral RNA-dependent RNA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
